A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: An observational cohort study

The Lancet Infectious Diseases

Volumn 14, Issue 10, 2014, Pages 967-975

  Yaw, Lai Kin ^a   Robinson, James Owen ^a,b   Ho, Kwok Ming ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BLOOD CULTURE; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; LONG TERM CARE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROGNOSIS; RECURRENT INFECTION; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS INFECTION; SURVIVAL TIME; AUSTRALIA; BACTEREMIA; DRUG EFFECTS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL; VERY ELDERLY;

ANTIINFECTIVE AGENT; METICILLIN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTEREMIA; COHORT STUDIES; FEMALE; HOSPITALS; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MORBIDITY; PATIENT READMISSION; PROGNOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS;

EID: 84908146317     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70876-X     Document Type: Article

References (32)

1. Malani PN, Rana MM, Banerjee M, Bradley SF Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status. J Am Geriatric Soc 2008, 56:1485-1489.
2. Jacobsson G, Gustafsson E, Andersson R Outcome for invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis 2008, 27:839-848.
3. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006, 25:181-185.
4. Hall RG, Hazlewood KA, Brouse SD, et al. Empiric guideline-recommended weight-baed vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Pharmacol Toxicol 2013, 14:12.
5. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbel IB Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012, 25:362.
6. Turnidge JD, Kotsanas D, Munckhof W, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009, 191:368-373.
7. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002, 162:25-32.
8. Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S aureus. Clin Infect Dis 2008, 46:799-806.
9. Cosgrove SE, Sakoulas G, Perenceivich EN, Scwwaber MJ, Karchmer AW, Carmeli Y Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
10. Whitby M, McLaws ML, Berry G Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001, 175:264-267.
11. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002, 162:2229-2235.
12. Kang CI, Song JH, Chung DR, et al. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect 2010, 61:299-306.
13. Holmes NE, Turnidge JD, Munckhof WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentration. J Infect Dis 2011, 204:340-347.
14. Holmes NE, Turnidge JD, Munckhof WJ, et al. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2013, 19:1163-1168.
15. Haessler S, Mackenzie T, Kirkland KB Long-term outcomes following infection with methicillin-resistant or methicillin-susceptible Staphylococcus aureus. J Hosp Infect 2008, 69:39-45.
16. Ho KM, Robinson JO Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Anaesth Intensive Care 2009, 37:457-463.
17. Quezada Joaquin NM, Diekema DJ, Perencevich EN, Bailey G, Winokur PL, Schweizer ML Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans. Antimicrob Agents Chemother 2013, 57:1169-1172.
18. Ridgway JP, Peterson LR, Brown EC, et al. Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: one-year infection risk. PLoS One 2013, 8:e79716.
19. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2006, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA. 7th edition.
20. Robinson JO, Pearson JC, Christiansen KJ, Coombs GW, Murray RJ Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis 2009, 28:353-361.
21. Costa AM, Kay I, Palladino S Rapid detection of mecA and nuc genes in staphylococci by real-time multiplex polymerase chain reaction. Diagn Microbiol Infect Dis 2005, 51:13-17.
22. Lucet JC, Grenet K, Armand-Lefevre L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005, 26:121-126.
23. McClelland RS, Fowler VG, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med 1999, 159:1244-1247.
24. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
25. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17.
26. Kopp BJ, Nix DE, Armstrong EP Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004, 38:1377-1382.
27. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174.
28. Bassetti M, Trecarichi EM, Mesini A, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2012, 18:862-869.
29. Aung AK, Skinner MJ, Lee FJ, Cheng AC Changing epidemiology of bloodstream infection pathogens over time in adult non-specilaty patients at an Australia tertiary hospital. Commun Dis Intell Q Rep 2012, 36:E333-E341.
30. Coombs GW1, Monecke S, Pearson JC, et al. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol 2011, 11:215.
31. Williamson DA, Coombs GW, Nimmo GR Staphylococcus aureus "Down Under": contemporary epidemiology of Staphylococcus aureus in Australia, New Zealand and the south west Pacific. Clin Microbiol Infect 2014, published online May 31. 10.1111/1469-0691.12702.
32. Robinson JO, Pozzi-Langhi S, Phillips M, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012, 31:2421-2428.